Position in HAE
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$4,946,325
+$1,270,019 QoQ
Shares Held
65,951
+1.1% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#5
of 65 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HAE Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026ISTHMUS PARTNERS, LLC holds $28,738,925 across 7 Medical Devices names. HAE ranks #2 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DXCM |
Dexcom Inc
|
186,266 | $12,545,015 | |
| 2 | HAE |
Haemonetics Corp
This page
|
65,951 | $4,946,325 | |
| 3 | BFLY |
Butterfly Network, Inc.
|
564,222 | $4,750,749 | |
| 4 | UFPT |
Ufp Technologies Inc
|
12,448 | $3,300,338 | |
| 5 | IRMD |
Iradimed Corp
|
25,586 | $2,444,998 | |
| 6 | HYPR |
Hyperfine, Inc.
|
313,350 | $423,022 | |
| 7 | ABT |
Abbott Laboratories
|
3,620 | $328,478 |
All Filings in HAE
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,946,325 | 65,951 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $3,676,306 | 65,229 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $5,418,941 | 67,610 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $3,007,355 | 61,702 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,372,148 | 45,197 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,698,650 | 42,465 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $3,140,377 | 40,220 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,196,712 | 39,770 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,978,982 | 48,096 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,100,043 | 48,038 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,529,602 | 17,888 | Shares | Sole | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||